sec filing
SK
NASDAQ · SKYE
Skye Bioscience, Inc.
Healthcare · Biotechnology
$2.04
Down-$0.04 (-1.92%)
Updated Sep 12, 2026, 1:17 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 37.01M
- P/E ratio
- -1.08
- Dividend yield
- 0.00%
- 52-week range
- $0.28 – $3.56
- Volume
- 66.18K
- Avg. volume
- 819.32K
Price performance
SKYE price history
1M range · 20 trading sessions · Daily adjusted prices
SKYE closed at $2.04 after 20 trading sessions, up 306.78% for the selected period.
- Last close
- $2.04
- Period change
- +306.78%
- Period low
- $0.42
- Period high
- $2.87
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $2.08 | $2.09 | $1.99 | $2.04 | 66.18K |
| Sep 10, 2026 | $2.20 | $2.2399 | $2.02 | $2.08 | 47.79K |
| Sep 9, 2026 | $1.88 | $2.25 | $1.88 | $2.23 | 172.31K |
| Sep 8, 2026 | $1.97 | $1.97 | $1.80 | $1.88 | 106.51K |
| Sep 4, 2026 | $1.77 | $1.95 | $1.77 | $1.86 | 183.11K |
| Sep 3, 2026 | $1.84 | $1.89 | $1.77 | $1.78 | 22.25K |
| Sep 2, 2026 | $1.79 | $2.05 | $1.76 | $1.84 | 134.64K |
| Sep 1, 2026 | $1.69 | $1.81 | $1.64 | $1.80 | 51.91K |
| Aug 31, 2026 | $1.75 | $1.80 | $1.665 | $1.68 | 70.74K |
| Aug 28, 2026 | $1.95 | $1.95 | $1.76 | $1.775 | 78.29K |
| Aug 27, 2026 | $2.00 | $2.02 | $1.95 | $1.95 | 52.98K |
| Aug 26, 2026 | $2.02 | $2.05 | $1.8429 | $2.02 | 111.35K |
| Aug 25, 2026 | $2.10 | $2.155 | $2.0003 | $2.015 | 65.26K |
| Aug 24, 2026 | $2.26 | $2.32 | $1.97 | $2.17 | 162.27K |
| Aug 21, 2026 | $2.2432 | $2.272 | $2.04 | $2.24 | 121.82K |
| Aug 20, 2026 | $2.424 | $2.60 | $2.208 | $2.2432 | 199.78K |
| Aug 19, 2026 | $2.728 | $3.0216 | $2.40 | $2.4472 | 173.46K |
| Aug 18, 2026 | $3.0776 | $3.5616 | $2.80 | $2.872 | 227.83K |
| Aug 17, 2026 | $0.5703 | $0.5857 | $0.4128 | $0.4151 | 9.44M |
| Aug 14, 2026 | $0.86 | $0.88 | $0.4732 | $0.5015 | 6.6M |
Latest SKYE news
The latest Smart Investors Daily articles mentioning SKYE.
Stock researchCompany · Earnings
Loading stock research…

